BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

AutoGenomics New RVP Assay Addresses Current Challenge to Detect Flu A - Swine H1N1


5/22/2009 8:24:44 AM

CARLSBAD, Calif., May 21 /PRNewswire/ -- AutoGenomics, a leader in developing automated molecular testing solutions, announced today that a Canadian team comprised of the Canada Research Chair in Medical Genomics, Professor Jacques Corbeil and Canada Research Chair on new viruses and antiviral resistance, Professor Guy Boivin has used its enhanced respiratory virus panel assay to test for the presence of the new Flu A - Swine H1N1 virus. "The assay for research use only detected the presence of both the circulating Flu A strains and the new Flu A - H1N1 strain," said Dr. Corbeil. He further stated that "the assay distinguished the new strain from the others as well as determined the presence of an additional 24 viruses that could potentially co-infect the patients, a factor that may increase the severity of the disease."

"This assay will be of great help in the coming flu seasons and facilitate improving hospital control strategies to understand the role of co- infections in the severity of swine flu cases and enable the selection of antiviral agents in the management of influenza infections," said Dr. Boivin.

The tests, conducted at the CHUL hospital affiliated with Laval University were part of an effort from the Canadian Institute of Health Research to promote research in this area of important societal need.

About AutoGenomics

AutoGenomics, Inc., a privately held company based in Carlsbad, CA, has developed the first automated, microarray based multiplexing diagnostic platforms that can be used to assess disease signatures with novel genomic and proteomic markers in the area of genetic disorders, infectious disease, cancer and pharmacogenetics. With the discovery of genes and their link to various disease states the platform has the versatility to revolutionize the way patients are diagnosed, monitored and managed leading to the era of personalized medicine. www.autogenomics.com.

CONTACT: Ram Vairavan, Senior Vice President Sales & Marketing,
AutoGenomics, +1-760-804-7378, ext. 305, rvairavan@autogenomics.com

Web site: http://www.autogenomics.com/



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES